{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T19:00:13Z","timestamp":1770231613033,"version":"3.49.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T00:00:00Z","timestamp":1697932800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010609","name":"Gda\u0144ski Uniwersytet Medyczny","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010609","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jtct.2023.10.015","type":"journal-article","created":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T09:55:04Z","timestamp":1697968504000},"page":"99.e1-99.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Incidence and Role of Recipient-Specific Antibodies in Allogeneic Hematopoietic Cell Transplantation from Mismatched Related Donors"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7752-5839","authenticated-orcid":false,"given":"Alicja","family":"Sadowska-Klasa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Dukat-Mazurek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Zieli\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"D\u0119bska-Zielkowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Piekarska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gra\u017cyna","family":"Moszkowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9850-2206","authenticated-orcid":false,"given":"Patrycja","family":"Mensah-Glanowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0986-8936","authenticated-orcid":false,"given":"Jan Maciej","family":"Zaucha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2023.10.015_bib0001","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1182\/blood.2021011281","article-title":"HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis","volume":"138","author":"Gooptu","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.10.015_bib0002","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/TP.0b013e3181b9d710","article-title":"High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation","volume":"88","author":"Ciurea","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.jtct.2023.10.015_bib0003","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s15010-017-1016-1","article-title":"A review of infectious complications after haploidentical hematopoietic stem cell transplantations","volume":"45","author":"Atilla","year":"2017","journal-title":"Infection"},{"key":"10.1016\/j.jtct.2023.10.015_bib0004","article-title":"Donor specific HLA antibody in hematopoietic stem cell transplantation: implications for donor selection","volume":"13:916200","author":"Krummey","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2023.10.015_bib0005","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/j.1537-2995.2009.02556.x","article-title":"Prevalence of HLA antibodies in remotely transfused or alloexposed volunteer blood donors","volume":"50","author":"Kakaiya","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.jtct.2023.10.015_bib0006","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/tan.14704","article-title":"Prevalence and risk factors of antibodies to HLA according to different cut-off values of mean fluorescence intensity in haploidentical allograft candidates: a prospective study of 3805 subjects","volume":"100","author":"Ma","year":"2022","journal-title":"HLA"},{"key":"10.1016\/j.jtct.2023.10.015_bib0007","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1111\/j.1537-2995.2009.02206.x","article-title":"The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy","volume":"49","author":"Triulzi","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.jtct.2023.10.015_bib0008","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/s41409-022-01674-x","article-title":"Reduced-intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid leukemia: a study from the ALWP of the EBMT","volume":"57","author":"Devillier","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.10.015_bib0009","unstructured":"Raiola AM, Angelucci E, Sica S, Bacigalupo A. Haploidentical bone marrow transplants with post transplant cyclophosphamide on day\u00a0+\u00a03\u00a0+\u00a05: the Genova protocol [e-pub ahead of print]. Blood Rev. doi: 10.1016\/j.blre.2022.101031, accessed XXXFor ref #9, please provide accessed date for e-pub ahead of print."},{"key":"10.1016\/j.jtct.2023.10.015_bib0010","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41409-018-0279-1","article-title":"Myeloablative and reduced-intensity conditioning in HLA-haploidentical peripheral blood stem cell transplantation using post-transplant cyclophosphamide","volume":"54","author":"Sugita","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.10.015_bib0011","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","article-title":"International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai Acute GVHD International Consortium","volume":"22","author":"Harris","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.10.015_bib0012","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood-2014-03-564997","article-title":"Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults","volume":"124","author":"Jodele","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.10.015_bib0013","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1038\/s41409-021-01283-0","article-title":"Transplant-associated thrombotic microangiopathy: theoretical considerations and a practical approach to an unrefined diagnosis","volume":"56","author":"Young","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.10.015_bib0014","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.blre.2014.11.001","article-title":"A new paradigm: diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury","volume":"29","author":"Jodele","year":"2015","journal-title":"Blood Rev"},{"key":"10.1016\/j.jtct.2023.10.015_bib0015","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jtct.2022.11.015","volume":"29","author":"Schoettler","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.10.015_bib0016","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/bmt.2016.130","article-title":"Revised diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation","volume":"51","author":"Mohty","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.10.015_bib0017","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00251-017-0989-3","article-title":"Infectious pathogens may trigger specific allo-HLA reactivity via multiple mechanisms","volume":"69","author":"D'Orsogna","year":"2017","journal-title":"Immunogenetics"},{"key":"10.1016\/j.jtct.2023.10.015_bib0018","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1111\/j.1600-6143.2011.03604.x","article-title":"De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients","volume":"11","author":"Katerinis","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jtct.2023.10.015_bib0019","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.humimm.2018.06.003","article-title":"Prevalence and risk factors of antibodies to human leukocyte antigens in haploidentical stem cell transplantation candidates: a multi-center study","volume":"79","author":"Huo","year":"2018","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jtct.2023.10.015_bib0020","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1111\/j.1537-2995.2010.02589.x","article-title":"Identification of specificities of antibodies against human leukocyte antigens in blood donors","volume":"50","author":"Endres","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.jtct.2023.10.015_bib0021","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000509946","article-title":"Leukocyte-reactive antibodies in female blood donors: the Austrian experience","volume":"48","author":"Sch\u00f6nbacher","year":"2021","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.jtct.2023.10.015_bib0022","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2215\/CJN.00700117","article-title":"Donor-specific antibodies in kidney transplant recipients","volume":"13","author":"Zhang","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jtct.2023.10.015_bib0023","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/bmt.2011.131","article-title":"Risk and prevention of graft failure in patients with preexisting donor-specific HLA antibodies undergoing unmanipulated haploidentical SCT","volume":"47","author":"Yoshihara","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.10.015_bib0024","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.bbmt.2013.01.016","article-title":"Partially mismatched transplantation and human leukocyte antigen donor-specific antibodies","volume":"19","author":"Gladstone","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.10.015_bib0025","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41409-022-01578-w","article-title":"The impact of HLA donor-specific antibodies on engraftment and the evolving desensitization strategies","volume":"57","author":"File","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.10.015_bib0026","doi-asserted-by":"crossref","DOI":"10.1177\/09636897221132502","article-title":"A case of daratumumab-induced significant decrease in donor-specific HLA antibodies and remission induction before haploidentical stem cell transplantation in a refractory B-ALL patient","volume":"31","author":"Li","year":"2022","journal-title":"Cell Transplant"},{"key":"10.1016\/j.jtct.2023.10.015_bib0027","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41409-017-0062-8","article-title":"The European Society for Blood and Marrow Transplantation (EBMT) consensus guidelines for the detection and treatment of donor-specific anti-HLA antibodies (DSA) in haploidentical hematopoietic cell transplantation","volume":"53","author":"Ciurea","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.10.015_bib0028","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1182\/asheducation-2018.1.585","article-title":"TACO and TRALI: biology, risk factors, and prevention strategies","volume":"2018","author":"Roubinian","year":"2018","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jtct.2023.10.015_bib0029","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood-2018-10-860809","article-title":"Transfusion-associated circulatory overload and transfusion-related acute lung injury","volume":"133","author":"Semple","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.10.015_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2021.100926","article-title":"Transfusion-related acute lung injury (TRALI): potential pathways of development, strategies for prevention and treatment, and future research directions","volume":"53","author":"Tung","year":"2022","journal-title":"Blood Rev"},{"key":"10.1016\/j.jtct.2023.10.015_bib0031","first-page":"1049","article-title":"Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab","volume":"135","author":"Jodele","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.10.015_bib0032","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1200\/JCO.21.02389","article-title":"Narsoplimab, a mannan-binding lectin-associated serine protease-2 inhibitor, for the treatment of adult hematopoietic stem-cell transplantation-associated thrombotic microangiopathy","volume":"40","author":"Khaled","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.10.015_bib0033","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3390\/jcm11030623","article-title":"Endothelial dysfunction after hematopoietic stem cell transplantation: a review based on physiopathology","volume":"11","author":"Milone","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.jtct.2023.10.015_bib0034","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1053\/j.seminoncol.2012.09.005","article-title":"Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantation","volume":"39","author":"Luznik","year":"2012","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jtct.2023.10.015_bib0035","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1182\/blood-2014-11-608406","article-title":"Role of naive-derived T memory stem cells in T-cell reconstitution following allogeneic transplantation","volume":"125","author":"Roberto","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.10.015_bib0036","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1182\/blood-2014-11-608539","article-title":"Generation of human memory stem T cells after haploidentical T-replete hematopoietic stem cell transplantation","volume":"125","author":"Cieri","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.10.015_bib0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3960\/jslrt.20040","article-title":"Immune reconstitution after T-cell replete HLA haploidentical hematopoietic stem cell transplantation using high-dose post-transplant cyclophosphamide","volume":"61","author":"Maeda","year":"2021","journal-title":"J Clin Exp Hematop"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723016378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723016378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:12:04Z","timestamp":1763003524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636723016378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2666636723016378"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2023.10.015","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and Role of Recipient-Specific Antibodies in Allogeneic Hematopoietic Cell Transplantation from Mismatched Related Donors","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2023.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}